<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82544">
  <stage>Registered</stage>
  <submitdate>22/01/2008</submitdate>
  <approvaldate>23/01/2008</approvaldate>
  <actrnumber>ACTRN12608000037303</actrnumber>
  <trial_identification>
    <studytitle>The effects of exercise rehabilitation on mobility in home-dwelling patients with dementia - a randomized, controlled, intervention study</studytitle>
    <scientifictitle>Dementia patients and their caregivers-exercise rehabilitation vs. usual care - mobility assessed with Guralnik tests</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Dementia</healthcondition>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Physiotherapy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients allocated to intervention are randomized to receive geriatric physiotherapy and rehabilitation either individually by a physiotherapist at home (one hour twice a week for 12 months, to increase and improve muscular strength and control, mobility, gait control and balance), or as group therapy sessions in a day care center by phsyiotherapists (4 hour sessions twice a week for 12 months,  to increase and improve muscular strength and control, mobility, gait control and balance)</interventions>
    <comparator>Usual care involves all care and procedures which are available for dementia patients within the Finnish health care system</comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Mobility according to Guralnik tests</outcome>
      <timepoint>12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Physical function (Barthel index), institutionalization, behavioral symptoms, falls, caregiver burden, cost-effectiveness, total mortality</outcome>
      <timepoint>12 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of Alzheimer's disease, home-dwelling with spouse,65 years or older,frail</inclusivecriteria>
    <inclusiveminage>65</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>terminal disease, hemiparesis, immobile</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>280</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Finland</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>KELA</primarysponsorname>
    <primarysponsoraddress>Nordenskioldinkatu 12 00250 Helsinki</primarysponsoraddress>
    <primarysponsorcountry>Finland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>KELA</fundingname>
      <fundingaddress>Nordenskioldinkatu 12 00250 Helsinki</fundingaddress>
      <fundingcountry>Finland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Charities/Societies/Foundations</sponsortype>
      <sponsorname>Vanhustyon keskusliitto</sponsorname>
      <sponsoraddress>Malmin kauppatie 26  00700 Helsinki</sponsoraddress>
      <sponsorcountry>Finland</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite>none</trialwebsite>
    <publication>none</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Timo Strandberg</name>
      <address>Aapistie 1  90014 Oulun yliopisto</address>
      <phone>+358405969285</phone>
      <fax />
      <email>timo,strandberg@oulu.fi</email>
      <country>Finland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Timo Strandberg</name>
      <address>Aapistie 1,  90014 Oulun yliopisto</address>
      <phone>+358405969285</phone>
      <fax />
      <email>timo.strandberg@oulu.fi</email>
      <country>Finland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Timo Strandberg</name>
      <address>Aapistie 1  90014 Oulun yliopisto</address>
      <phone>+358405969285</phone>
      <fax />
      <email>timo,strandberg@oulu.fi</email>
      <country>Finland</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>